Say No To Trading
Public Markets Investor, Opportunistic Buying & Cost-Basis Management
Marvell's risk/reward is no longer favorable after the stock ran three to four times from the $70s in March, when it was the most obviously undervalued chip stock. Jensen Huang's call for a $1T company is partly driven by his dislike of Broadcom's Hock Tan, and the Celestial AI angle is overhyped relative to the value it adds. A bounce is likely from here, but there is no case for adding exposure at the current price. x.com x.com x.comÂ
Marvell looks too expensive at 17x price to sales when peers in its space trade around 10x. @DGretta_Author argues its revenue relative to its market cap leaves the stock further to drop. x.comÂ
Marvell is priced too aggressively, with its valuation not yet reflecting actual capacity. Especially in the late stage of a raging bull market, stocks priced this aggressively are best avoided. x.comÂ
Marvell looks interesting at less than 30x calendar-2027 EPS against expected 60-70% annual EPS growth, but overpaying for Lumentum could drive its shares lower. Marvell could pay up to $110B, roughly a 30% premium; the stock-versus-debt mix is unclear, and Lumentum holders might own a third of the combined company. If the deal falls apart, Marvell could rise 10-12%. x.comÂ
Marvell is expensive, growing more slowly and not founder-led, so owning it directly makes little sense. x.comÂ
Marvell's ambitious long-range outlook is encouraging about hyperscaler and AI-lab spending plans, but hitting it depends on AI revenue and token consumption soaring through decade's end. Even if its FY28 estimates rise again, Marvell trades at a healthy premium to Nvidia and Broadcom, especially on a GAAP basis, and those two are growing fast too. x.comÂ
Marvell's $70-90 billion FY31 revenue target looks credible: COO Chris Koopmans said key foundry, substrate and packaging suppliers get five-year forecasts and had already seen it before investor day. A $500 price target still looks too aggressive for now; Marvell must show it can grow its networking and photonics segment to deserve a safe price increase. x.com x.comÂ
Marvell wasted the AI boom and leadership's handling raises doubts. During last summer's bull run, when demand across the AI buildout was higher than ever, it still missed earnings and its CEO said they didn't know whether the demand was real. The stock fell 10-15% immediately and kept bleeding toward its April tariff-crash lows. x.comÂ
Lumentum's 109% year-on-year growth and sold-out capacity through 2029 make selling its AI optics exposure questionable. Bloomberg reported Marvell is in advanced talks to buy it; the appeal depends on the price, especially when holders of an $80 billion Lumentum would become holders of a $320 billion-plus Marvell growing 37%. x.comÂ
A Lumentum deal would put Marvell in a much better competitive position, making its shares an obvious buy here, especially for existing Lumentum shareholders. If the deal breaks, Marvell shares would jump sharply; a moderate premium could mean near-term weakness or sideways trading but would be a great long-term deal. A big premium could push shares down further, though much of that risk is already priced in. x.com x.comÂ
Marvell's potential Lumentum acquisition may fail to increase per-share value because the added profits may not cover dilution and financing costs. A simplified calculation using reported market values implies roughly 38%-45% more shares, requiring about 45% more combined net profit to preserve EPS; debt would add interest and repayment pressure. If the price already reflects future growth, a control premium and possible customer concerns add risk. x.comÂ
